Bristol-Myers Squibb Canada Co. et al. v. Sandoz Canada Inc.

Call to arrange a consultation

2025

T-504-19

Resolved

6(1) PM(NOC) Regulations

Application under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations regarding apixaban.

Counsel to:

Sandoz Canada Inc.

The decision is reported

Counsel

Associate